Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Dendreon

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Dendreon's 2012 oncology sales performance.

Dendreon Corporation

BMS appoints new commercial leader, Davies joins Eisai and more

BMS appoints new commercial leader, Davies joins Eisai and more

He has also held a number of roles for Dendreon Corporation and Roche’s Genentech, where he worked on its Avastin franchise strategy.

Cancer immunotherapy: What's on the horizon?

Cancer immunotherapy: What's on the horizon? Vaccines. While the first therapeutic cancer vaccines have reached the market, eg Dendreon’s Provenge and Antigenics’ Oncophage, commercially they haven’t yet made much impact and the pipeline has been

Dendreon appoints new R&D lead

Dendreon appoints new R&D lead Cancer vaccine company Dendreon has added to its senior team, appointing Dr Bruce Brown as its new senior vice president, medical. ... Dr Brown’s new role will see him head the company’s R&D organisation, including research and discovery, clinical

Deal Watch January 2017

Deal Watch January 2017 Bringing in an additional $819.9m in cash, Valeant also sold its equity interest in Dendreon (manufacturer of Provenge, a personalised immunotherapy) to the Sanpower Group. ... Dendreon had only been acquired in February 2015 from bankruptcy for $495m

Valeant uncouples Dendreon and skincare brands to cut debt

Valeant uncouples Dendreon and skincare brands to cut debt Agrees deals worth $2.1bn with L’Oreal and Sanpower Group. Dendreon's Provenge cancer vaccine. ... cosmetics giant L'Oreal for $1.3bn and the Dendreon cancer vaccine business to China's Sanpower Group for around $820m.

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics